Parkside Financial Bank & Trust Cor Medix Inc. Transaction History
Parkside Financial Bank & Trust
- $976 Million
- Q3 2025
A detailed history of Parkside Financial Bank & Trust transactions in Cor Medix Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 1 shares of CRMD stock, worth $11. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 36
97.22%
Holding current value
$11
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CRMD
# of Institutions
212Shares Held
41.9MCall Options Held
1.33MPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA4.5MShares$51 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.3 Million0.0% of portfolio
-
Marshall Wace, LLP London, X03.47MShares$39.4 Million0.05% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.32MShares$37.7 Million0.74% of portfolio
-
State Street Corp Boston, MA1.84MShares$20.8 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $467M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...